$3250 | Single User
$6500 | Site License
$9750 | Enterprise License

Chronic Heart Failure - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Published by Delve Insight: 14 Feb 2018 | 201405 | In Stock

Introduction

DelveInsight's "Chronic Heart Failure - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Chronic Heart Failure epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered

• United States

• EU5 (Germany, France, Italy, Spain, and the United Kingdom)

• Japan

Study Period: 2016-2027

Chronic Heart Failure Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Chronic Heart Failure in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Chronic Heart Failure outlook. It also includes the explanation of changing trends of epidemiology outlining the Chronic Heart Failure scenario.

Chronic Heart Failure Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Chronic Heart Failure thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

• The report covers detailed overview of Chronic Heart Failure explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

• The Chronic Heart Failure Report assesses the disease risk and burden and highlights the unmet needs

• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

• 10 Year Forecast

• 7MM Coverage

• Total Cases in Chronic Heart Failure

Key assessments

• Patient Segmentation in Chronic Heart Failure

• Chronic Heart Failure Risk & Burden

• Factors driving growth in a specific Chronic Heart Failure patient population

Table of Contents
for Chronic Heart Failure - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

  • 1. Report Introduction

    2. Chronic Heart Failure Epidemiology Overview at a Glance

    2.1. Patient Share Distribution of Chronic Heart Failure in 2017

    2.2. Patient Share Distribution of Chronic Heart Failure in 2027

    3. Disease Background and Overview: Chronic Heart Failure

    3.1. Introduction

    3.2. Symptoms

    3.3. Etiology

    3.4. Risk Factors

    3.5. Pathophysiology

    3.6. Diagnosis

    3.7. Treatment

    4. Epidemiology and Patient Population

    4.1. Key Findings

    4.2. Total Prevalent/ Incident Patient Population of Chronic Heart Failure in 7MM

    4.3. Total Prevalent/ Incident Patient Population of Chronic Heart Failure in 7MM – By Countries

    5. Epidemiology of Chronic Heart Failure by Countries

    5.1. United States

    5.1.1. Assumptions and Rationale

    5.1.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.1.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.1.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.1.5. Diagnosed Cases of the Chronic Heart Failure

    5.2. EU5

    5.3. Assumptions and Rationale

    5.4. Germany

    5.4.1. Assumptions and Rationale

    5.4.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.4.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.4.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.4.5. Diagnosed Cases of the Chronic Heart Failure

    5.5. France

    5.5.1. Assumptions and Rationale

    5.5.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.5.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.5.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.5.5. Diagnosed Cases of the Chronic Heart Failure

    5.6. Italy

    5.6.1. Assumptions and Rationale

    5.6.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.6.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.6.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.6.5. Diagnosed Cases of the Chronic Heart Failure

    5.7. Spain

    5.7.1. Assumptions and Rationale

    5.7.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.7.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.7.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.7.5. Diagnosed Cases of the Chronic Heart Failure

    5.8. United Kingdom

    5.8.1. Assumptions and Rationale

    5.8.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.8.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.8.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.8.5. Diagnosed Cases of the Chronic Heart Failure

    5.9. Japan

    5.9.1. Assumptions and Rationale

    5.9.2. Prevalent/Incident Cases of the Chronic Heart Failure

    5.9.3. Sub-Type Specific cases of the Chronic Heart Failure *

    5.9.4. Sex- Specific Cases of the Chronic Heart Failure *

    5.9.5. Diagnosed Cases of the Chronic Heart Failure

    6. Unmet Needs of the Chronic Heart Failure

    7. Appendix

    8. Report Methodology

    8.1. Sources

    9. DelveInsight Capabilities

    10. Disclaimer

    11. About DelveInsight

    *Indication Specific

List Of Tables
in Chronic Heart Failure - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Table 1: Total Prevalent/Incident Cases of the Chronic Heart Failure in 7MM

Table 2: Total Prevalent/Incident Cases of the Chronic Heart Failure in 7MM by Countries

Table 3: Prevalent/Incident Cases of the Chronic Heart Failure in United States (2016-2027)

Table 4: Sub-Type Specific cases of the Chronic Heart Failure in United States (2016-2027)*

Table 5: Sex- Specific Cases of the Chronic Heart Failure in United States (2016-2027)*

Table 6: Diagnosed Cases of the Chronic Heart Failure in United States (2016-2027)

Table 7: Prevalent/Incident Cases of the Chronic Heart Failure in Germany (2016-2027)

Table 8: Sub-Type Specific cases of the Chronic Heart Failure in Germany (2016-2027) *

Table 9: Sex- Specific Cases of the Chronic Heart Failure in Germany (2016-2027) *

Table 10: Diagnosed Cases of the Chronic Heart Failure in Germany (2016-2027)

Table 11: Prevalent/Incident Cases of the Chronic Heart Failure in France (2016-2027)

Table 12: Sub-Type Specific cases of the Chronic Heart Failure in France (2016-2027) *

Table 13: Sex- Specific Cases of the Chronic Heart Failure in France (2016-2027) *

Table 14: Diagnosed Cases of the Chronic Heart Failure in France (2016-2027)

Table 15: Prevalent/Incident Cases of the Chronic Heart Failure in Italy (2016-2027)

Table 16: Sub-Type Specific cases of the Chronic Heart Failure in Italy (2016-2027) *

Table 17: Sex- Specific Cases of the Chronic Heart Failure in Italy (2016-2027) *

Table 18: Diagnosed Cases of the Chronic Heart Failure in Italy (2016-2027)

Table 19: Prevalent/Incident Cases of the Chronic Heart Failure in Spain (2016-2027)

Table 20: Sub-Type Specific cases of the Chronic Heart Failure in Spain (2016-2027) *

Table 21: Sex- Specific Cases of the Chronic Heart Failure in Spain (2016-2027) *

Table 22: Diagnosed Cases of the Chronic Heart Failure in Spain (2016-2027)

Table 23: Prevalent/Incident Cases of the Chronic Heart Failure in UK (2016-2027)

Table 24: Sub-Type Specific cases of the Chronic Heart Failure in UK (2016-2027) *

Table 25: Sex- Specific Cases of the Chronic Heart Failure in UK (2016-2027) *

Table 26: Diagnosed Cases of the Chronic Heart Failure in UK (2016-2027)

Table 27: Prevalent/Incident Cases of the Chronic Heart Failure in Japan (2016-2027)

Table 28: Sub-Type Specific cases of the Chronic Heart Failure in Japan (2016-2027) *

Table 29: Sex- Specific Cases of the Chronic Heart Failure in Japan (2016-2027) *

Table 30: Diagnosed Cases of the Chronic Heart Failure in Japan (2016-2027)

List Of Figures, Charts and Diagrams
in Chronic Heart Failure - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Table 1: Total Prevalent/Incident Cases of the Chronic Heart Failure in 7MM

Table 2: Total Prevalent/Incident Cases of the Chronic Heart Failure in 7MM by Countries

Table 3: Prevalent/Incident Cases of the Chronic Heart Failure in United States (2016-2027)

Table 4: Sub-Type Specific cases of the Chronic Heart Failure in United States (2016-2027)*

Table 5: Sex- Specific Cases of the Chronic Heart Failure in United States (2016-2027)*

Table 6: Diagnosed Cases of the Chronic Heart Failure in United States (2016-2027)

Table 7: Prevalent/Incident Cases of the Chronic Heart Failure in Germany (2016-2027)

Table 8: Sub-Type Specific cases of the Chronic Heart Failure in Germany (2016-2027) *

Table 9: Sex- Specific Cases of the Chronic Heart Failure in Germany (2016-2027) *

Table 10: Diagnosed Cases of the Chronic Heart Failure in Germany (2016-2027)

Table 11: Prevalent/Incident Cases of the Chronic Heart Failure in France (2016-2027)

Table 12: Sub-Type Specific cases of the Chronic Heart Failure in France (2016-2027) *

Table 13: Sex- Specific Cases of the Chronic Heart Failure in France (2016-2027) *

Table 14: Diagnosed Cases of the Chronic Heart Failure in France (2016-2027)

Table 15: Prevalent/Incident Cases of the Chronic Heart Failure in Italy (2016-2027)

Table 16: Sub-Type Specific cases of the Chronic Heart Failure in Italy (2016-2027) *

Table 17: Sex- Specific Cases of the Chronic Heart Failure in Italy (2016-2027) *

Table 18: Diagnosed Cases of the Chronic Heart Failure in Italy (2016-2027)

Table 19: Prevalent/Incident Cases of the Chronic Heart Failure in Spain (2016-2027)

Table 20: Sub-Type Specific cases of the Chronic Heart Failure in Spain (2016-2027) *

Table 21: Sex- Specific Cases of the Chronic Heart Failure in Spain (2016-2027) *

Table 22: Diagnosed Cases of the Chronic Heart Failure in Spain (2016-2027)

Table 23: Prevalent/Incident Cases of the Chronic Heart Failure in UK (2016-2027)

Table 24: Sub-Type Specific cases of the Chronic Heart Failure in UK (2016-2027) *

Table 25: Sex- Specific Cases of the Chronic Heart Failure in UK (2016-2027) *

Table 26: Diagnosed Cases of the Chronic Heart Failure in UK (2016-2027)

Table 27: Prevalent/Incident Cases of the Chronic Heart Failure in Japan (2016-2027)

Table 28: Sub-Type Specific cases of the Chronic Heart Failure in Japan (2016-2027) *

Table 29: Sex- Specific Cases of the Chronic Heart Failure in Japan (2016-2027) *

Table 30: Diagnosed Cases of the Chronic Heart Failure in Japan (2016-2027)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

201405 | DIEI0054

Number of Pages

50

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
The Outlook for Wearable Health Tech in Managing Chronic Disease
IntroductionWearable tech – the new golden ticket for patient adherence?Wearable technology is being...
01 May 2016 by FirstWord Pharma USD $695 More Info
Chronic Obstructive Pulmonary Disorder (COPD): Update Bulletin [Feb 2016]
IntroductionThis edition presents key opinion leader (KOL) views on recent developments in the chron...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events with the potential to shape the targeted trea...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionIn the last few years the emergence of new targeted therapies such as AbbVie’s/Janssen’s...
01 Sep 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight
IntroductionCombination therapy is set to take centre stage in the treatment of COPD as leading comp...
20 Apr 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionChronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until rece...
27 May 2014 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
IntroductionThe prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, ...
20 Jan 2014 by FirstWord Pharma USD $7,495 More Info
Physician Views: Life after Gleevec in the chronic myeloid leukaemia (CML) market?
ScopeNovartis' Gleevec is widely credited as being one of the most important drug launches of all ti...
01 Jun 2013 by FirstWord Pharma USD $695 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Chronic Heart Failure - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data